Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis.

Dultz G, Piiper A, Zeuzem S, Kronenberger B, Waidmann O.

Aliment Pharmacol Ther. 2014 Dec 19. doi: 10.1111/apt.13061. [Epub ahead of print]

PMID:
25523381
[PubMed - as supplied by publisher]
2.

Identifying indications for percutaneous (PTC) vs. endoscopic ultrasound (EUS)- guided "rendezvous" procedure in biliary obstruction and incomplete endoscopic retrograde cholangiography (ERC).

Albert JG, Finkelmeier F, Friedrich-Rust M, Kronenberger B, Trojan J, Zeuzem S, Sarrazin C.

Z Gastroenterol. 2014 Oct;52(10):1157-63. doi: 10.1055/s-0034-1366629. Epub 2014 Oct 14.

PMID:
25313627
[PubMed - in process]
3.

A novel, stiff-shaft, flexible-tip guidewire for cannulation of biliary stricture during endoscopic retrograde cholangiopancreatography: a randomized trial.

Albert JG, Lucas K, Filmann N, Herrmann E, Schröder O, Sarrazin C, Trojan J, Kronenberger B, Bojunga J, Zeuzem S, Friedrich-Rust M.

Endoscopy. 2014 Oct;46(10):857-61. doi: 10.1055/s-0034-1377628. Epub 2014 Sep 10.

PMID:
25208030
[PubMed - in process]
4.

Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.

Dultz G, Gerber L, Farnik H, Berger A, Vermehren J, Pleli T, Zeuzem S, Piiper A, Kronenberger B, Waidmann O.

J Viral Hepat. 2014 Sep 2. doi: 10.1111/jvh.12309. [Epub ahead of print]

PMID:
25181653
[PubMed - as supplied by publisher]
5.

Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study.

Pleli T, Martin D, Kronenberger B, Brunner F, Köberle V, Grammatikos G, Farnik H, Martinez Y, Finkelmeier F, Labocha S, Ferreirós N, Zeuzem S, Piiper A, Waidmann O.

PLoS One. 2014 Jul 25;9(7):e103532. doi: 10.1371/journal.pone.0103532. eCollection 2014.

PMID:
25062038
[PubMed - in process]
Free PMC Article
6.

Commentary: vitamin D deficiency and liver cancer - cause, effect or myth? Authors' reply.

Finkelmeier F, Kronenberger B, Köberle V, Bojunga J, Zeuzem S, Trojan J, Piiper A, Waidmann O.

Aliment Pharmacol Ther. 2014 Jun;39(12):1429-30. doi: 10.1111/apt.12772. No abstract available.

PMID:
24849152
[PubMed - indexed for MEDLINE]
7.

Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study.

Finkelmeier F, Kronenberger B, Köberle V, Bojunga J, Zeuzem S, Trojan J, Piiper A, Waidmann O.

Aliment Pharmacol Ther. 2014 May;39(10):1204-12. doi: 10.1111/apt.12731. Epub 2014 Mar 29.

PMID:
24684435
[PubMed - indexed for MEDLINE]
8.

Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation.

Farnik H, Zimmermann T, Herrmann E, Bechstein WO, Kronenberger B, Galle PR, Labocha S, Ferreiros N, Geisslinger G, Zeuzem S, Sarrazin C, Welker MW.

Liver Int. 2014 Mar 20. doi: 10.1111/liv.12532. [Epub ahead of print]

PMID:
24649882
[PubMed - as supplied by publisher]
9.

[Cytokeratin 18 as marker for non-invasive diagnosis and prognosis of acute and chronic liver diseases].

Canbay A, Feldstein A, Kronenberger B, Schulze-Osthoff K, Bantel H.

Z Gastroenterol. 2014 Mar;52(3):290-5. doi: 10.1055/s-0033-1356138. Epub 2014 Mar 12. Review. German.

PMID:
24622872
[PubMed - indexed for MEDLINE]
10.

Single measurement of hemoglobin predicts outcome of HCC patients.

Finkelmeier F, Bettinger D, Köberle V, Schultheiß M, Zeuzem S, Kronenberger B, Piiper A, Waidmann O.

Med Oncol. 2014 Jan;31(1):806. doi: 10.1007/s12032-013-0806-2. Epub 2013 Dec 11.

PMID:
24326985
[PubMed - indexed for MEDLINE]
11.

Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers.

Köberle V, Pleli T, Schmithals C, Augusto Alonso E, Haupenthal J, Bönig H, Peveling-Oberhag J, Biondi RM, Zeuzem S, Kronenberger B, Waidmann O, Piiper A.

PLoS One. 2013 Sep 20;8(9):e75184. doi: 10.1371/journal.pone.0075184. eCollection 2013.

PMID:
24073250
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[interferon-free treatment of hepatitis C: how and when will it become reality? [corrected]].

Kronenberger B, Welzel TM, Zeuzem S.

Dtsch Med Wochenschr. 2013 Sep;138(36):1796-800. doi: 10.1055/s-0033-1343331. Epub 2013 Sep 3. German. No abstract available. Erratum in: Dtsch Med Wochenschr. 2013 Sep;138(36) e26.

PMID:
24002882
[PubMed]
13.

Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis.

Dultz G, Seelhof M, Herrmann E, Welker MW, Friedrich-Rust M, Teuber G, Kronenberger B, von Wagner M, Vermehren J, Sarrazin C, Zeuzem S, Hofmann WP.

PLoS One. 2013 Aug 1;8(8):e71262. doi: 10.1371/journal.pone.0071262. Print 2013.

PMID:
23936497
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Investigation of viral escape mutations within HCV p7 during treatment with amantadine in patients with chronic hepatitis C.

Vermehren A, Welsch C, Elsler U, Vermehren J, Herrmann E, Sarrazin C, von Wagner M, Susser S, Hofmann WP, Kronenberger B, Zeuzem S, Mihm U.

Antivir Ther. 2013;18(6):803-11. doi: 10.3851/IMP2663. Epub 2013 Jul 3.

PMID:
23824381
[PubMed - in process]
15.

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.

Köberle V, Kronenberger B, Pleli T, Trojan J, Imelmann E, Peveling-Oberhag J, Welker MW, Elhendawy M, Zeuzem S, Piiper A, Waidmann O.

Eur J Cancer. 2013 Nov;49(16):3442-9. doi: 10.1016/j.ejca.2013.06.002. Epub 2013 Jun 26.

PMID:
23810247
[PubMed - indexed for MEDLINE]
16.

Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy.

Köberle V, Waidmann O, Kronenberger B, Andrei A, Susser S, Füller C, Perner D, Zeuzem S, Sarrazin C, Piiper A.

J Viral Hepat. 2013 Aug;20(8):530-5. doi: 10.1111/jvh.12075. Epub 2013 Feb 18.

PMID:
23808991
[PubMed - indexed for MEDLINE]
17.

Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.

Waidmann O, Köberle V, Bettinger D, Trojan J, Zeuzem S, Schultheiß M, Kronenberger B, Piiper A.

J Hepatol. 2013 Oct;59(4):769-79. doi: 10.1016/j.jhep.2013.06.008. Epub 2013 Jun 17.

PMID:
23792028
[PubMed - indexed for MEDLINE]
18.

High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma.

Bergis D, Kassis V, Ranglack A, Koeberle V, Piiper A, Kronenberger B, Zeuzem S, Waidmann O, Radeke HH.

Transl Oncol. 2013 Jun 1;6(3):311-8. Print 2013 Jun.

PMID:
23730411
[PubMed]
Free PMC Article
19.

Interleukin-22 serum levels are a negative prognostic indicator in patients with hepatocellular carcinoma.

Waidmann O, Kronenberger B, Scheiermann P, Köberle V, Mühl H, Piiper A.

Hepatology. 2014 Mar;59(3):1207. doi: 10.1002/hep.26528. Epub 2013 Dec 13. No abstract available.

PMID:
23729376
[PubMed - indexed for MEDLINE]
20.

Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients.

Farnik H, Bojunga J, Berger A, Allwinn R, Waidmann O, Kronenberger B, Keppler OT, Zeuzem S, Sarrazin C, Lange CM.

Hepatology. 2013 Oct;58(4):1270-6. doi: 10.1002/hep.26488. Epub 2013 Aug 7.

PMID:
23703797
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk